CD169<sup>+</sup> macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice.

Moore-Fried, Jamie; Paul, Mahinder; Jing, Zhixin; Fooksman, David; Lauvau, Gregoire · Elife · 2022

basic_science · Level V

Where this comes from

Abstract

Plasmacytoid dendritic cells (pDCs) are the most potent producer of type I interferon (IFN), but how pDC is primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169<sup>+</sup> macrophages (MPs), pDC initiates type I IFN-I secretion in the bone marrow (BM) of infected mice via cell-intrinsic TLR7 sensing and cell-extrinsic STING sensing. Herein we show that CD169<sup>+</sup> MP and TLR7 sensing are both required for pDC arrest during priming, suggesting CD169<sup>+</sup> MP are the source of TLR7 ligands. We establish that TLR7 sensing in pDC and chemotaxis are both required for pDC arrest and functional communication with CD169<sup>+</sup> MP in the BM. Lastly, we demonstrate that STING sensing in CD169<sup>+</sup> MP control pDC initiation of type I IFN production while also regulating pDC clustering and retention/egress from the BM. Collectively, these results link pDC acquisition of type I IFN-secreting capacity with changes in their motility, homing and interactions with CD169<sup>+</sup> MP during infection. Thus, targeting this cellular interaction may help modulate type I IFN to improve outcomes of microbial infections and autoimmune diseases.

Medical subject headings